Consolidated Statement Of Cash Flows
Concept |
2024-04-01 to 2025-03-31 |
2024-04-01 to 2025-03-31 |
2024-04-01 to 2025-03-31 |
As at 2025-03-31 |
2024-04-01 to 2025-03-31 |
2024-04-01 to 2025-03-31 |
2024-04-01 to 2025-03-31 |
2024-04-01 to 2025-03-31 |
2024-04-01 to 2025-03-31 |
2023-04-01 to 2024-03-31 |
2023-04-01 to 2024-03-31 |
2023-04-01 to 2024-03-31 |
2023-04-01 to 2024-03-31 |
2023-04-01 to 2024-03-31 |
2023-04-01 to 2024-03-31 |
2023-04-01 to 2024-03-31 |
As at 2024-03-31 |
2023-04-01 to 2024-03-31 |
As at 2023-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Consolidated statement of cash flows | |||||||||||||||||||
Statement of cash flows | |||||||||||||||||||
Cash flows from operating activities | |||||||||||||||||||
Profit (loss) |
137,237,000,000
JPY
|
137,237,000,000
JPY
|
70,000,000
JPY
|
— |
137,307,000,000
JPY
|
JPY
|
JPY
|
JPY
|
JPY
|
102,679,000,000
JPY
|
JPY
|
75,000,000
JPY
|
JPY
|
JPY
|
102,679,000,000
JPY
|
102,755,000,000
JPY
|
— |
JPY
|
— |
Depreciation and amortization | — | — | — | — |
65,595,000,000
JPY
|
— | — | — | — | — | — | — | — | — | — |
60,811,000,000
JPY
|
— | — | — |
Impairment losses (reversal of impairment losses) | — | — | — | — |
12,339,000,000
JPY
|
— | — | — | — | — | — | — | — | — | — |
1,651,000,000
JPY
|
— | — | — |
Decrease (increase) in inventories | — | — | — | — |
-8,526,000,000
JPY
|
— | — | — | — | — | — | — | — | — | — |
11,769,000,000
JPY
|
— | — | — |
Interest paid | — | — | — | — |
-809,000,000
JPY
|
— | — | — | — | — | — | — | — | — | — |
-609,000,000
JPY
|
— | — | — |
Net cash provided by (used in) operating activities | — | — | — | — |
217,908,000,000
JPY
|
— | — | — | — | — | — | — | — | — | — |
155,521,000,000
JPY
|
— | — | — |
Cash flows from investing activities | |||||||||||||||||||
Purchase of investment securities | — | — | — | — |
-762,000,000
JPY
|
— | — | — | — | — | — | — | — | — | — |
-723,000,000
JPY
|
— | — | — |
Proceeds from sale of investment securities | — | — | — | — |
55,000,000
JPY
|
— | — | — | — | — | — | — | — | — | — |
551,000,000
JPY
|
— | — | — |
Proceeds from sale of subsidiaries | — | — | — | — |
JPY
|
— | — | — | — | — | — | — | — | — | — |
1,871,000,000
JPY
|
— | — | — |
Other | — | — | — | — |
23,000,000
JPY
|
— | — | — | — | — | — | — | — | — | — |
10,000,000
JPY
|
— | — | — |
Net cash provided by (used in) investing activities | — | — | — | — |
-115,105,000,000
JPY
|
— | — | — | — | — | — | — | — | — | — |
-67,927,000,000
JPY
|
— | — | — |
Cash flows from financing activities | |||||||||||||||||||
Net increase (decrease) in short-term borrowings | — | — | — | — |
109,000,000
JPY
|
— | — | — | — | — | — | — | — | — | — |
72,000,000
JPY
|
— | — | — |
Dividends paid | — | — | — | — |
-38,040,000,000
JPY
|
— | — | — | — | — | — | — | — | — | — |
-36,041,000,000
JPY
|
— | — | — |
Other | — | — | — | — |
-75,000,000
JPY
|
— | — | — | — | — | — | — | — | — | — |
-16,000,000
JPY
|
— | — | — |
Net cash provided by (used in) financing activities | — | — | — | — |
-78,890,000,000
JPY
|
— | — | — | — | — | — | — | — | — | — |
-90,784,000,000
JPY
|
— | — | — |
Cash and cash equivalents | — | — | — |
363,344,000,000
JPY
|
— | — | — | — | — | — | — | — | — | — | — | — |
342,269,000,000
JPY
|
— |
329,966,000,000
JPY
|
Effect of exchange rate changes on cash and cash equivalents | — | — | — | — |
-2,837,000,000
JPY
|
— | — | — | — | — | — | — | — | — | — |
13,573,000,000
JPY
|
— | — | — |